Matthew R. Patterson, President & CEO at Audentes Therapeutics, Inc. (BOLD), sold 18,458 shares at $25.07 ($463K) on 2017-09-18, disclosed to the SEC on 2017-09-19.
Open-market sale of $463k BOLD by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 1,542 | $39K | 8.3% |
| 2 | $25.07 | 8,458 | $212K | 45.8% |
| 3 | $25.07 | 8,458 | $212K | 45.8% |
| Total | $25.06 avg | 18,458 | $463K | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |